Fulton Bank Has Decreased Abbvie (ABBV) Stake By $1.56 Million; Lyon William Homes (class A) (WLH) Sellers Decreased By 16.67% Their Shorts

William Lyon Homes (NYSE:WLH) Logo

Fulton Bank decreased Abbvie Inc (ABBV) stake by 21.89% reported in 2017Q4 SEC filing. Fulton Bank sold 16,283 shares as Abbvie Inc (ABBV)’s stock declined 6.31%. The Fulton Bank holds 58,093 shares with $5.62 million value, down from 74,376 last quarter. Abbvie Inc now has $150.18 billion valuation. The stock increased 0.40% or $0.38 during the last trading session, reaching $94.65. About 7.40M shares traded or 3.11% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since March 31, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Lyon William Homes (class A) (NYSE:WLH) had a decrease of 16.67% in short interest. WLH’s SI was 696,600 shares in March as released by FINRA. Its down 16.67% from 836,000 shares previously. With 338,700 avg volume, 2 days are for Lyon William Homes (class A) (NYSE:WLH)’s short sellers to cover WLH’s short positions. The SI to Lyon William Homes (class A)’s float is 2.94%. The stock increased 1.51% or $0.41 during the last trading session, reaching $27.49. About 578,151 shares traded or 18.35% up from the average. William Lyon Homes (NYSE:WLH) has risen 31.70% since March 31, 2017 and is uptrending. It has outperformed by 20.15% the S&P500.

William Lyon Homes, together with its subsidiaries, designs, constructs, markets, and sells single-family detached and attached homes. The company has market cap of $1.07 billion. It operates in six divisions: California, Arizona, Nevada, Colorado, Washington, and Oregon. It has a 22.17 P/E ratio. The firm sells its homes primarily to entry-level, and first-time and second-time move-up homebuyers under the Village Homes and Polygon Northwest Homes brands through in-house commissioned sales personnel and outside brokers.

Among 5 analysts covering William Lyon Homes (NYSE:WLH), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. William Lyon Homes has $35.0 highest and $20 lowest target. $27.75’s average target is 0.95% above currents $27.49 stock price. William Lyon Homes had 15 analyst reports since August 29, 2015 according to SRatingsIntel. The stock of William Lyon Homes (NYSE:WLH) earned “Hold” rating by UBS on Wednesday, January 17. The firm earned “Hold” rating on Wednesday, November 1 by Wedbush. As per Friday, September 4, the company rating was upgraded by Zacks. The stock has “Hold” rating by Wedbush on Friday, December 29. As per Thursday, January 12, the company rating was downgraded by JMP Securities. The company was maintained on Wednesday, November 1 by UBS. Wedbush upgraded William Lyon Homes (NYSE:WLH) on Thursday, February 8 to “Outperform” rating. As per Tuesday, December 6, the company rating was initiated by Wedbush. On Tuesday, February 21 the stock rating was maintained by Wedbush with “Neutral”. The stock of William Lyon Homes (NYSE:WLH) earned “Hold” rating by Zacks on Thursday, September 17.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26. They expect $1.78 EPS, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.82 billion for 13.29 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc has $15700 highest and $6 lowest target. $96.21’s average target is 1.65% above currents $94.65 stock price. Abbvie Inc had 85 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of AbbVie Inc. (NYSE:ABBV) earned “Market Perform” rating by BMO Capital Markets on Thursday, November 16. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by Credit Suisse on Monday, January 29. The stock of AbbVie Inc. (NYSE:ABBV) earned “Outperform” rating by Raymond James on Friday, September 2. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Wednesday, June 7 by BMO Capital Markets. Piper Jaffray maintained AbbVie Inc. (NYSE:ABBV) on Thursday, September 28 with “Buy” rating. Jefferies maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, July 14. Jefferies has “Buy” rating and $9400 target. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by SunTrust on Wednesday, July 22. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Friday, March 10 by Goldman Sachs. The rating was maintained by Bank of America with “Hold” on Monday, March 26. The rating was maintained by BMO Capital Markets with “Underperform” on Friday, March 23.

Fulton Bank increased Nationwide Mut Fds New stake by 23,531 shares to 436,500 valued at $11.33 million in 2017Q4. It also upped Advisers Invt Tr stake by 83,437 shares and now owns 2.97 million shares. Dominion Energy Inc (NYSE:D) was raised too.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It worsened, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Tru Of Virginia Va reported 0.28% of its portfolio in AbbVie Inc. (NYSE:ABBV). Marshwinds Advisory holds 1.45% or 32,358 shares. Beech Hill Inc reported 53,047 shares. Oppenheimer & reported 224,047 shares stake. Sonata Cap Gp Inc reported 3,520 shares. Cincinnati Specialty Underwriters Insurance owns 2.2% invested in AbbVie Inc. (NYSE:ABBV) for 27,200 shares. Kessler Inv Gru Llc reported 11,988 shares. Bokf Na owns 129,152 shares. Lsv Asset Management invested in 0.96% or 6.32 million shares. Meiji Yasuda Asset Mngmt Limited reported 0.67% stake. Ellington Mngmt Gru Limited accumulated 11,100 shares or 0.18% of the stock. Strategic Advsrs Lc reported 46,154 shares. Pinnacle Fincl Prtnrs holds 113,760 shares. Summit Wealth Advsr holds 82,940 shares. Moreover, Global X Mgmt Ltd Liability has 0.06% invested in AbbVie Inc. (NYSE:ABBV) for 27,521 shares.

Since October 30, 2017, it had 0 insider buys, and 12 selling transactions for $49.35 million activity. On Wednesday, February 28 Michael Robert A. sold $512,853 worth of AbbVie Inc. (NYSE:ABBV) or 4,294 shares. $8.57M worth of AbbVie Inc. (NYSE:ABBV) was sold by RICHMOND TIMOTHY J.. ALBAN CARLOS had sold 83,574 shares worth $9.57M on Wednesday, February 28. CHASE WILLIAM J had sold 70,928 shares worth $8.31 million on Wednesday, February 28. $2.95M worth of stock was sold by Schumacher Laura J on Wednesday, February 28. Gosebruch Henry O sold $1.66 million worth of stock. SEVERINO MICHAEL had sold 2,643 shares worth $311,684 on Wednesday, February 28.

AbbVie Inc. (NYSE:ABBV) Ratings Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: